180 related articles for article (PubMed ID: 34936968)
1. Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition.
Sreenivasmurthy SG; Iyaswamy A; Krishnamoorthi S; Senapati S; Malampati S; Zhu Z; Su CF; Liu J; Guan XJ; Tong BC; Cheung KH; Tan JQ; Lu JH; Durairajan SSK; Song JX; Li M
Phytomedicine; 2022 Feb; 96():153887. PubMed ID: 34936968
[TBL] [Abstract][Full Text] [Related]
2. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer's disease therapy.
Sreenivasmurthy SG; Iyaswamy A; Krishnamoorthi S; Reddi RN; Kammala AK; Vasudevan K; Senapati S; Zhu Z; Su CF; Liu J; Guan XJ; Chua KK; Cheung KH; Chen H; Zhang HJ; Zhang Y; Song JX; Kumar Durairajan SS; Li M
Front Mol Biosci; 2022; 9():1030534. PubMed ID: 36387280
[TBL] [Abstract][Full Text] [Related]
3. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
Fan SJ; Huang FI; Liou JP; Yang CR
Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
[TBL] [Abstract][Full Text] [Related]
4. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
8. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
9. Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid models.
Choi H; Kim HJ; Yang J; Chae S; Lee W; Chung S; Kim J; Choi H; Song H; Lee CK; Jun JH; Lee YJ; Lee K; Kim S; Sim HR; Choi YI; Ryu KH; Park JC; Lee D; Han SH; Hwang D; Kyung J; Mook-Jung I
Aging Cell; 2020 Jan; 19(1):e13081. PubMed ID: 31763743
[TBL] [Abstract][Full Text] [Related]
10. Yuan-Hu Zhi Tong Prescription Mitigates Tau Pathology and Alleviates Memory Deficiency in the Preclinical Models of Alzheimer's Disease.
Iyaswamy A; Krishnamoorthi SK; Liu YW; Song JX; Kammala AK; Sreenivasmurthy SG; Malampati S; Tong BCK; Selvarasu K; Cheung KH; Lu JH; Tan JQ; Huang CY; Durairajan SSK; Li M
Front Pharmacol; 2020; 11():584770. PubMed ID: 33192524
[TBL] [Abstract][Full Text] [Related]
11. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
[TBL] [Abstract][Full Text] [Related]
13. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
14. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
15. NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models.
Iyaswamy A; Krishnamoorthi SK; Song JX; Yang CB; Kaliyamoorthy V; Zhang H; Sreenivasmurthy SG; Malampati S; Wang ZY; Zhu Z; Tong BC; Cheung KH; Lu JH; Durairajan SSK; Li M
J Food Drug Anal; 2020 Jan; 28(1):132-146. PubMed ID: 31883601
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology.
Mondal P; Bai P; Gomm A; Bakiasi G; Lin CJ; Wang Y; Choi SH; Tanzi RE; Wang C; Zhang C
Adv Sci (Weinh); 2024 Jan; 11(1):e2304545. PubMed ID: 37990786
[TBL] [Abstract][Full Text] [Related]
17. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).
Li Y; Sang S; Ren W; Pei Y; Bian Y; Chen Y; Sun H
Eur J Med Chem; 2021 Dec; 226():113874. PubMed ID: 34619465
[TBL] [Abstract][Full Text] [Related]
19. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.
Cook C; Gendron TF; Scheffel K; Carlomagno Y; Dunmore J; DeTure M; Petrucelli L
Hum Mol Genet; 2012 Jul; 21(13):2936-45. PubMed ID: 22492994
[TBL] [Abstract][Full Text] [Related]
20. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
